PHARMING GRP SP. ADRS (PHG) — Long-term Investment Intensity
PHARMING GRP SP. ADRS (PHG) has a Long-term Investment Intensity of 1.7% as of December 2025. Long-term investments of €8.65 Million represent 1.7% of total assets of €499.96 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check PHARMING GRP SP. ADRS (PHG) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
PHARMING GRP SP. ADRS Long-term Investment Intensity (2021–2025)
This chart shows how PHARMING GRP SP. ADRS's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 1.7%, reflecting long-term investments of €8.65 Million against total assets of €499.96 Million EUR. For the complete balance sheet picture, see how large is PHARMING GRP SP. ADRS's balance sheet.
Annual Long-term Investment Intensity for PHARMING GRP SP. ADRS (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read PHG current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.7% | €8.65 Million | €499.96 Million | ▲ +0.7 pp |
| 2024 | 1.1% | €4.23 Million | €399.99 Million | ▼ -1.2 pp |
| 2023 | 2.2% | €10.40 Million | €462.85 Million | ▼ 0.0 pp |
| 2022 | 2.3% | €9.73 Million | €425.80 Million | ▲ +0.1 pp |
| 2021 | 2.2% | €8.65 Million | €397.31 Million | — |